Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ground floor.
Novartis, Bristol Myers join $72M funding for startup’s cancer radiotherapy R&D
Aktis Oncology is developing cancer radiation treatments intended to be more precise and potent compared to other radiotherapies. The startup is now out of stealth with $72 million in Series A financing.
presented by
The Top EAP Companies for Mental Health Support
Employee assistance programs have become essential tools for organizations aiming to address mental health challenges, reduce burnout and foster healthier workplaces.
Novartis spends $2.1B to snap up targeted radiotherapy drug for prostate cancer
Endocyte entered its targeted radioligand therapy, Lu-PSMA-617, into a Phase III study in June following Phase II data showing more than 60 percent response rate.
Elekta bets MRI is the next step in radiotherapy
The challenge with radiation and other cancer therapies is getting the right amount of treatment to the tumor and leaving healthy cells unscathed.